BioClinica, Inc., (NASDAQ: BIOC) a leading global provider of clinical trial services, is helping to advance the discipline of clinical data management and will demonstrate integrated eClinical and imaging data management technology and expertise at the 2009 Society of Clinical Data Management (SCDM) Annual Conference, October 4-6, 2009 in Seattle, WA (Booth # 401). Company experts will share their knowledge of the industry and case studies illustrating the results of improved clinical data management practices. BioClinica is the Diamond Sponsor of the SCDM 2009 Annual Conference.
Processing and managing clinical data is a time-consuming and costly challenge for today’s life science companies that spend billions of dollars every year on drug development and research. As advancements in technology and drug development procedures have increased the volume and complexity of clinical data over the past decade, a greater degree of expertise is required to manage all this information. From study start-up and initiation through data collection and the delivery of final data sets, BioClinica has the knowledge and expertise to deliver maximum results with minimal risk.
“Integrating technology with advanced service delivery eliminates the need for time consuming and costly data reconciliation at the end of a study,” said Mark Weinstein, President and CEO of BioClinica, Inc. “With these capabilities, BioClinica delivers next-generation clinical outsourcing results through improved, integrated, and accelerated clinical trial processes.”
BioClinica supports the SCDM goal of advancing the discipline of clinical data management. Case studies about two BioClinica clients, Pozen, Inc. and Amylin Pharmaceuticals, are finalists for the SCDM Data Driven award honoring the best advancements in clinical data management technology or service.